-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Dianthus Therapeutics, Maintains $46 Price Target

Benzinga·12/22/2025 13:37:47
語音播報
Wedbush analyst Laura Chico reiterates Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform and maintains $46 price target.